Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects

被引:186
作者
Fernández-Real, JM
Broch, M
Vendrell, J
Richart, C
Ricart, V
机构
[1] Univ Hosp Girona Dr Josep Trueta, Unitat Diabetol Endocrinol & Nutr, Girona 17007, Spain
[2] Univ Rovira & Virgili, Fac Med, Hosp Tarragona Joan XXIII, Unitat Endocrinol, Tarragona 43007, Spain
关键词
D O I
10.1210/jc.85.3.1334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several lines of evidence indicate that interleukin-6 (IL-6) is involved not only in the hepatic acute phase response but also in adipose tissue metabolism, lipoprotein lipase activity, and hepatic triglyceride secretion. A polymorphism in the IL-6 gene, associated with differences in IL-6 transcription rate, has been recently described. We aimed to study whether this IL-6 gene polymorphism leads to differences in fasting and postglucose load plasma lipids in healthy subjects. Subjects with G at position - 174 of the IL-6 gene were similar in age, sex, body mass index, and waist to hip ratio in comparison with carriers of the C allele. However, G carriers showed almost twice plasma triglycerides (1.5 +/- 0.9 us. 0.90 +/- 0.37 mmol/L; P = 0.01), very low-density lipoprotein (VLDL)-triglycerides (0.97 +/- 0.69 us. 0.42 +/- 0.2 mmol/L; P = 0.002), higher fasting (881 us. 458 lambda mol/L; P = 0.01), and postglucose load free fatty acids (299 vs. 90.5 mu mol/L; P = 0.03), slightly lower high-density lipoprotein-2 cholesterol (0.25 +/- 0.14 us. 0.39 +/- 0.26 mmol/L; P = 0.058), and similar cholesterol and LDL-cholesterol levels than carriers of the C allele. Serum IL-6 levels correlated positively with fasting triglycerides, VLDL-triglycerides, and postload free fatty acids (r = 0.61, 0.65 and 0.60, respectively; P < 0.001) and negatively with high-density lipoprotein-cholesterol (r = -0.42, P < 0.05). A tendency toward higher serum IL-6 levels was observed among G carriers (9.9 +/- 6.9 us. 6.85 +/- 1.7 pg/mL; P = 0.09). The - 174G construct was recently reported to show higher expression of IL-6 in He La cells and was associated with higher plasma IL-6 levels than the - 174C allele. Thus, the results of the present study suggest that subjects with the G allele, associated to higher IL-6 secretion, are prone to lipid abnormalities. Whether this polymorphism contributes to lipid alterations associated with ether metabolic disorders awaits additional studies.
引用
收藏
页码:1334 / 1339
页数:6
相关论文
共 22 条
  • [1] Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors
    Baggio, G
    Donazzan, S
    Monti, D
    Mari, D
    Martini, S
    Gabelli, C
    Dalla Vestra, M
    Previato, L
    Guido, M
    Pigozzo, S
    Cortella, I
    Crepaldi, G
    Franceschi, C
    [J]. FASEB JOURNAL, 1998, 12 (06) : 433 - 437
  • [2] Insulin resistance and inflammation in an evolutionary perspective:: the contribution of cytokine genotype/phenotype to thriftiness
    Fernández-Real, JM
    Ricart, W
    [J]. DIABETOLOGIA, 1999, 42 (11) : 1367 - 1374
  • [3] Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects
    Fernández-Real, JM
    Gutiérrez, C
    Ricart, W
    Castiñeira, MJ
    Vendrell, J
    Richart, C
    [J]. ATHEROSCLEROSIS, 1999, 146 (02) : 321 - 327
  • [4] The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels
    FernandezReal, JM
    Gutierrez, C
    Ricart, W
    Casamitjana, R
    FernandezCastaner, M
    Vendrell, J
    Richart, C
    Soler, J
    [J]. DIABETES, 1997, 46 (09) : 1468 - 1472
  • [5] The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
    Fishman, D
    Faulds, G
    Jeffery, R
    Mohamed-Ali, V
    Yudkin, JS
    Humphries, S
    Woo, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) : 1369 - 1376
  • [6] Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
    Fried, SK
    Bunkin, DA
    Greenberg, AS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 847 - 850
  • [7] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [8] GREENBERG AS, 1992, CANCER RES, V52, P4113
  • [9] GRUNFELD C, 1992, DIABETES S2, V41, P97
  • [10] Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
    Harris, TB
    Ferrucci, L
    Tracy, RP
    Corti, MC
    Wacholder, S
    Ettinger, WH
    Heimovitz, H
    Cohen, HJ
    Wallace, R
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) : 506 - 512